Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy Barclays PLC

Start price
€676.00
07.02.24 / 50%
Target price
€751.76
07.02.25
Performance (%)
1.54%
Price
€685.20
26.04.24
Summary
This prediction is currently active. With a performance of 1.54%, the BUY prediction by Barclays_PLC for Eli Lilly Corp. is trending in the right direction. Dividends of €1.21 are taken into consideration when calculating the performance. This prediction currently runs until 07.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Eli Lilly Corp. 0.543% 0.543%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Barclays_PLC for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) 1.54%
Target price 751.761
Change
Ends at 07.02.25

Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Barclays PLC from $680.00 to $810.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat

Stopped prediction by Barclays_PLC for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€580.50
23.01.24
€625.12
23.01.25
18.24%
26.04.24